TY - JOUR
T1 - Intraoperative bacterial contamination and activity of different antimicrobial prophylaxis regimens in primary knee and hip replacement
AU - Rivera, Alba
AU - Sánchez, Alba
AU - Luque, Sonia
AU - Mur, Isabel
AU - Puig, Lluís
AU - Crusi, Xavier
AU - González, José Carlos
AU - Sorlí, Luisa
AU - González, Aránzazu
AU - Horcajada, Juan Pablo
AU - Navarro, Ferran
AU - Benito, Natividad
N1 - Funding Information:
Funding: This research was funded by the Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness (grant number PI15/1026). Co-funded by European Regional Development Fund/European Social Fund “Investing in your future”.
Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2021/1/1
Y1 - 2021/1/1
N2 - Surgical antimicrobial prophylaxis (SAP) is important for the prevention of prosthetic joint infections (PJIs) and must be effective against the microorganisms most likely to contaminate the surgical site. Our aim was to compare different SAP regimens (cefazolin, cefuroxime, or vancomycin, alone or combined with gentamicin) in patients undergoing total knee (TKA) and hip (THA) arthro-plasty. In this preclinical exploratory analysis, we analyzed the results of intraoperative sample cultures, the ratio of plasma antibiotic levels to the minimum inhibitory concentrations (MICs) for bacteria isolated at the surgical wound and ATCC strains, and serum bactericidal titers (SBT) against the same microorganisms. A total of 132 surgical procedures (68 TKA, 64 THA) in 128 patients were included. Cultures were positive in 57 (43.2%) procedures (mostly for coagulase-negative staphylococci and Cutibacterium spp.); the rate was lower in the group of patients receiving combination SAP (adjusted OR 0.475, CI95% 0.229–0.987). The SAP regimens evaluated achieved plasma levels above the MICs in almost all of intraoperative isolates (93/94, 98.9%) and showed bactericidal activity against all of them (SBT range 1:8–1:1024), although SBTs were higher in patients receiving cefazolin and gentamicin-containing regimens. The potential clinical relevance of these findings in the prevention of PJIs remains to be determined.
AB - Surgical antimicrobial prophylaxis (SAP) is important for the prevention of prosthetic joint infections (PJIs) and must be effective against the microorganisms most likely to contaminate the surgical site. Our aim was to compare different SAP regimens (cefazolin, cefuroxime, or vancomycin, alone or combined with gentamicin) in patients undergoing total knee (TKA) and hip (THA) arthro-plasty. In this preclinical exploratory analysis, we analyzed the results of intraoperative sample cultures, the ratio of plasma antibiotic levels to the minimum inhibitory concentrations (MICs) for bacteria isolated at the surgical wound and ATCC strains, and serum bactericidal titers (SBT) against the same microorganisms. A total of 132 surgical procedures (68 TKA, 64 THA) in 128 patients were included. Cultures were positive in 57 (43.2%) procedures (mostly for coagulase-negative staphylococci and Cutibacterium spp.); the rate was lower in the group of patients receiving combination SAP (adjusted OR 0.475, CI95% 0.229–0.987). The SAP regimens evaluated achieved plasma levels above the MICs in almost all of intraoperative isolates (93/94, 98.9%) and showed bactericidal activity against all of them (SBT range 1:8–1:1024), although SBTs were higher in patients receiving cefazolin and gentamicin-containing regimens. The potential clinical relevance of these findings in the prevention of PJIs remains to be determined.
KW - Antibiotic levels
KW - Hip arthroplasty
KW - Intraoperative cultures
KW - Knee arthroplasty
KW - Prosthetic joint infection
KW - Prosthetic joint infection prevention
KW - Serum bactericidal titer
KW - Surgical antimicrobial prophylaxis
KW - Surgical site infection prevention
UR - http://www.scopus.com/inward/record.url?scp=85098785272&partnerID=8YFLogxK
U2 - 10.3390/antibiotics10010018
DO - 10.3390/antibiotics10010018
M3 - Artículo
C2 - 33375415
AN - SCOPUS:85098785272
VL - 10
SP - 1
EP - 14
JO - Antibiotics
JF - Antibiotics
IS - 1
M1 - 18
ER -